Series E Preferred Stock Financing of ZipLine Medical

Represented HighCape Partners in connection with a $12 million Series E Preferred Stock financing of Zipline Medical with participation from MVM Life Science Partners. ZipLine is an innovator in cost-effective, non-invasive surgical skin closure devices. For more information, click here.